Dr. O'Donnell is a Primary Care Clinical Liaison with Medical Affairs, Roche Labs and is Board Certified in Pharmacotherapy (BCPS). Additionally she is a certified disease manager (CDM) in several primary care therapeutic areas including: anticoagulation, asthma, hyperlipidemia and diabetes. In addition to her clinical and scientific leadership responsibilities at Roche, she maintains a clinical role at the Scott & White Lipid Clinic in Temple, Texas.

Her primary research interests are related to primary care practice, including evaluation of satisfaction, outcomes, and economic impact of patients' receiving ambulatory pharmaceutical care services. She has been involved in multiple clinical research investigations of heart disease risk factors and effects of medications on patients' lipoprotein profile. An additional research area includes evaluation and optimization of patient comprehension of the informed consent process.

•O'Donnell DC, Brown CM, Piziak, VK. Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic. AJHP 2001;58:1017-21.


•O'Donnell DC, Chen N, Piziak VK. LDL-Cholesterol Goal Attainment and Maintenance by Patients Referred to a Pharmacist-Coordinated Lipid Clinic. Am J Health-Syst Pharm 2001;58:325-30.


•Miller CK, O'Donnell DC, Searight HR, Barbarash RA. The Deaconess Informed Consent Comprehension Test: an assessment tool for clinical research subjects. Pharmacotherapy 1996;16:872-878.


Book Chapters

•OO'Donnell DC. Obesity. In: Schwinghammer, editor. Pharmacotherapy Casebook: A patient-focused approach, third edition. Stamford, CT: Appleton and Lange, (accepted)


•O'Donnell DC. Obesity. In: Schwinghammer, editor. An Instructors Guide to Accompany Pharmacotherapy Casebook: A patient-focused approach, third edition. Stamford, CT: Appleton and Lange, (accepted)


•O'Donnell DC. Chapter 59: Diabetes Mellitus. In: ASHP PharmPrep, Ginsberg DB (ed) ,ASHP, Bethesda, MD 2001, pp 211-214.


•O'Donnell DC. Chapter 60: Diabetes Mellitus. In: ASHP PharmPrep, Ginsberg DB (ed) ,ASHP, Bethesda, MD 2001; pp 215-218.


•O'Donnell DC Chapter 61: Hyperlipidemia In: ASHP PharmPrep, Ginsberg DB (ed) ,ASHP, Bethesda, MD 2001 pp 219-222.


•O'Donnell DC. Chapter 62: Hyperlipidemia. In: ASHP PharmPrep, Ginsberg DB (ed) ,ASHP, Bethesda, MD 2001 pp. 223-226.


•O'Donnell DC. Chapter 31: Obesity. In: Schwinghammer, editor. Pharmacotherapy Casebook: A patient-focused approach, second edition. Stamford, CT: Appleton and Lange, 2000, p 326-328.


•O'Donnell DC. Chapter 31: Obesity. In: Schwinghammer, editor. An Instructors Guide to Accompany Pharmacotherapy Casebook: A patient-focused approach, second edition. Stamford, CT: Appleton and Lange, 2000, p 427-31.


•O'Donnell DC, Browne BA. Non-pharmacologic and complementary approaches to arthritis management (Module 3). Arthritis and Pain Care Program. Alexandria, VA. 1998, p NCA1-20.


•Reviews Articles /Continuing Education/ Case Reports O'Donnell DC. Cardiovascular disease in women. Texas Pharmacy 2000;8-12.


•O'Donnell DC, Hooper J. Increased INR in a Patient Taking Warfarin and Celecoxib. J Pharm Technology 2001;17:3-5.


•O'Donnell DC. (book review) Informed Consent: Patient Autonomy and Clinician Beneficence Within Health Care, 2nd edition, by Stephen Wear. Ann Pharmacotherapy 2000;34:275-6.


•O'Donnell DC, Iser TC, Diabetes: 2 The Therapeutic Management of Diabetes Mellitus. In: Supernaw RB, editor. Diabetes I-IV. Lawrence, KS: Pharmat Inc, 2000


•O'Donnell DC. Hyperlipidemia: Current concepts on the role of HMG-CoAs. In: Cardiovascular Counseling: A Supplement to Drug Topics. October 1998(suppl): 16s-20s.


•O'Donnell DC. (book review) Stand Tall! Every Woman's Guide to Preventing and Treating Osteoporosis, 2nd edition, by Morris Notelvitz. AJHP 1999;56:1272-73.


•O'Donnell DC, Shamsie SG. Diabetes -- An opportunity for therapy management. Pharmat 1997;13(3):1-17.


•O'Donnell DC, Church CA. Therapeutics of Parkinson's Disease. Pharmacy Times 1997;63:57-67.


Selected Recent Presentations

•"Using Technology in a Lipid Clinic," In: Practice Management Series - Using Technology to Advance Patient Care. American College of Clinical Pharmacy, 2001 Spring Practice and Research Forum, Salt Lake City, Utah, April 25, 2001.


•"Hormonal Issues in Women with Diabetes," In: Symposium on Women's Healthcare Issues. American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL December 7, 1999.


•"Development, Evaluation and Outcomes of Pharmacist-Coordinated Lipid Clinic." American College of Clinical Pharmacy, International Congress on Clinical Pharmacy, Orlando, FL, April 11, 1999


•"OTC Treatments for Osteoarthritis." 146th Annual Meeting and Exposition. The American Pharmaceutical Association, San Antonio, Texas, March 6, 1999


•"Emerging Concepts in Oral Contraceptives," In: Symposium on Women's Healthcare Issues. American Society of Health-System Pharmacists Midyear Clinical Meeting, Las Vegas, NV December 7, 1998.


•"Scientific Integrity: Where do our responsibilities end?" Symposium, Contemporary Challenges in Health Care Ethics, ACCP 1998 Spring Practice and Research Forum, Palm Springs, CA, April 7, 1998.


•"Use of Alternative Medicines in Patients Followed in a Lipid Clinic." Cardiology Practice and Research Network, ACCP 1997 Annual Meeting, Phoenix, AZ, November 10, 1997.

Scott & White Personal Page

UT Home Page | Pharmacy Home Page | Pharmacy Practice Home Page

October 6, 2003 Faculty Directory College of Pharmacy at UT Austin Comments to: pharmacy@www.utexas.edu